HealthSouth Corporation (NYSE:HLS) has earned a consensus recommendation of “Hold” from the thirteen analysts that are presently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and seven have given a buy recommendation to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $48.83.
HLS has been the topic of a number of analyst reports. Piper Jaffray Companies reiterated a “hold” rating and issued a $50.00 price target on shares of HealthSouth Corporation in a research report on Thursday, August 3rd. Zacks Investment Research upgraded shares of HealthSouth Corporation from a “hold” rating to a “buy” rating and set a $49.00 price target on the stock in a research report on Wednesday, August 2nd. BidaskClub downgraded shares of HealthSouth Corporation from a “hold” rating to a “sell” rating in a research report on Thursday, July 13th. Mizuho increased their price target on shares of HealthSouth Corporation from $44.00 to $47.00 and gave the company a “neutral” rating in a research report on Monday, July 10th. Finally, ValuEngine upgraded shares of HealthSouth Corporation from a “hold” rating to a “buy” rating in a research report on Friday, July 7th.
In related news, CEO Mark J. Tarr sold 22,625 shares of the firm’s stock in a transaction on Monday, August 7th. The shares were sold at an average price of $43.00, for a total value of $972,875.00. Following the completion of the transaction, the chief executive officer now directly owns 283,134 shares of the company’s stock, valued at $12,174,762. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.60% of the stock is currently owned by company insiders.
Institutional investors have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP boosted its position in HealthSouth Corporation by 0.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 735,979 shares of the company’s stock worth $30,353,000 after buying an additional 5,030 shares during the period. Thrivent Financial for Lutherans bought a new position in HealthSouth Corporation during the fourth quarter worth approximately $633,000. UBS Asset Management Americas Inc. boosted its position in HealthSouth Corporation by 4.3% in the fourth quarter. UBS Asset Management Americas Inc. now owns 72,087 shares of the company’s stock worth $2,973,000 after buying an additional 2,959 shares during the period. Teachers Advisors LLC boosted its position in HealthSouth Corporation by 2.4% in the fourth quarter. Teachers Advisors LLC now owns 581,924 shares of the company’s stock worth $23,999,000 after buying an additional 13,850 shares during the period. Finally, Macquarie Group Ltd. boosted its position in HealthSouth Corporation by 6.7% in the fourth quarter. Macquarie Group Ltd. now owns 507,135 shares of the company’s stock worth $20,914,000 after buying an additional 31,730 shares during the period. 97.96% of the stock is owned by hedge funds and other institutional investors.
HealthSouth Corporation (HLS) opened at 43.82 on Friday. The stock’s 50 day moving average is $45.57 and its 200-day moving average is $44.19. The stock has a market capitalization of $4.33 billion, a PE ratio of 15.97 and a beta of 0.61. HealthSouth Corporation has a 52 week low of $36.97 and a 52 week high of $49.71.
HealthSouth Corporation (NYSE:HLS) last issued its earnings results on Monday, July 31st. The company reported $0.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.68 by $0.03. The company had revenue of $981.30 million for the quarter, compared to analyst estimates of $976.46 million. HealthSouth Corporation had a net margin of 6.70% and a return on equity of 25.07%. The company’s revenue for the quarter was up 6.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.69 EPS. Equities research analysts forecast that HealthSouth Corporation will post $2.71 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Monday, October 2nd will be paid a $0.25 dividend. The ex-dividend date of this dividend is Friday, September 29th. This is a boost from HealthSouth Corporation’s previous quarterly dividend of $0.24. This represents a $1.00 annualized dividend and a dividend yield of 2.28%. HealthSouth Corporation’s dividend payout ratio (DPR) is currently 35.29%.
About HealthSouth Corporation
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
What are top analysts saying about HealthSouth Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for HealthSouth Corporation and related companies.